357 related articles for article (PubMed ID: 28243940)
1. Modulation of the host immune response by respiratory syncytial virus proteins.
Schmidt ME; Varga SM
J Microbiol; 2017 Mar; 55(3):161-171. PubMed ID: 28243940
[TBL] [Abstract][Full Text] [Related]
2. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.
Collins PL; Melero JA
Virus Res; 2011 Dec; 162(1-2):80-99. PubMed ID: 21963675
[TBL] [Abstract][Full Text] [Related]
3. Human Respiratory Syncytial Virus: An Introduction.
Jorquera PA; Anderson L; Tripp RA
Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
[TBL] [Abstract][Full Text] [Related]
4. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
Lee JY; Chang J
J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
[TBL] [Abstract][Full Text] [Related]
5. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
[TBL] [Abstract][Full Text] [Related]
6. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
Harris J; Werling D
Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
[TBL] [Abstract][Full Text] [Related]
8. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.
Boyoglu-Barnum S; Chirkova T; Anderson LJ
Front Immunol; 2019; 10():1675. PubMed ID: 31402910
[TBL] [Abstract][Full Text] [Related]
9. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
[TBL] [Abstract][Full Text] [Related]
11. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
12. The adaptive immune response to respiratory syncytial virus.
Varga SM; Braciale TJ
Curr Top Microbiol Immunol; 2013; 372():155-71. PubMed ID: 24362689
[TBL] [Abstract][Full Text] [Related]
13. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
[TBL] [Abstract][Full Text] [Related]
14. Advances in and the potential of vaccines for respiratory syncytial virus.
Jorquera PA; Oakley KE; Tripp RA
Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
[TBL] [Abstract][Full Text] [Related]
16. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.
San-Juan-Vergara H; Peeples ME
Immunol Allergy Clin North Am; 2019 Aug; 39(3):321-334. PubMed ID: 31284923
[TBL] [Abstract][Full Text] [Related]
17. Immunopathology of RSV: An Updated Review.
Bergeron HC; Tripp RA
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960746
[TBL] [Abstract][Full Text] [Related]
18. The host response and molecular pathogenesis associated with respiratory syncytial virus infection.
Oshansky CM; Zhang W; Moore E; Tripp RA
Future Microbiol; 2009 Apr; 4(3):279-97. PubMed ID: 19327115
[TBL] [Abstract][Full Text] [Related]
19. Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
Muralidharan A; Russell MS; Larocque L; Gravel C; Sauvé S; Chen Z; Li C; Chen W; Cyr T; Rosu-Myles M; Wang L; Li X
Vaccine; 2019 Jul; 37(30):4031-4039. PubMed ID: 31186190
[TBL] [Abstract][Full Text] [Related]
20. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.
Whelan JN; Tran KC; van Rossum DB; Teng MN
J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
